Bill Gillette

Bill Gillette is a freelance writer based in Richmond Heights, Ohio.

Articles by Bill Gillette

The American Board of Medical Specialties (ABMS) and its member boards have established limits to the number of years that can elapse between a physician’s completion of residency training and achievement of board certification.

A new study suggests patients with basal cell carcinoma (BCC) who experienced a recent, severe stressful life event and who experienced childhood emotional abuse are more likely to have poorer immune responses to the disease.

Researchers in India report they have developed a radiation spot treatment for basal cell carcinoma (BCC) that destroys facial tumors without surgery or major radiation therapy in 80 percent of patients in a small study.

Washington - Though Congress adjourned for recess without taking action to forestall the 21 percent cut in Medicare reimbursement that took effect April 1, the Centers for Medicare and Medicaid Services (CMS) has acted to buy doctors more time, MedPage Today reports.

Gaithersburg, Md. - A panel of advisers to the Food and Drug Administration has recommended that the agency place tighter controls on artificial tanning, the Associated Press reports. Those controls could range from requiring parental consent forms to banning the practice in teens under age 18.

Fort Worth, Texas - The Food and Drug Administration has approved the lotion formulation of adapalene (Differin 0.1 percent, Galderma) for the topical treatment of acne in patients age 12 and older, Medscape Today reports.

Bristol, Tenn. - The Food and Drug Administration has approved Zyclara, a new cream made by Graceway Pharmaceuticals of Bristol, Tenn., for treatment of actinic keratoses, news source TriCities.com reports.

Washington - The Food and Drug Administration says Novartis AG and Astellas Pharma may need to expand warning labels on their eczema drugs following dozens of new reported cases of cancer and infection in children, Reuters reports.

Rolling Meadows, Ill. - Lawrence Field, M.D., has donated $100,000 to the American Society for Dermatologic Surgery (ASDS) to start the Lawrence Field, M.D., International Dermatologic Surgery Educational Exchange Fund.

Berkeley Heights, N.J. - Pharmaceutical company Genta Inc., based here, announced recently that a phase 3 drug trial for the melanoma drug Genasense showed no statistically significant benefit compared with a placebo, reports news source Foxbusiness.com.

Cleveland - The National Institutes of Health has awarded Pratima Karnik, Ph.D., assistant professor of dermatology at Cleveland’s Case Western Reserve University, a grant of $1.77 million to fund a five-year study titled “PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia,” reports the Cicatricial Alopecia Research Foundation (CARF).

Minneapolis - Results of a recently completed study appear to establish the efficacy of Levulan Photodynamic Therapy (PDT) in reducing the recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), reports PRNewswire.

London - Researchers from Cancer Research UK's Cambridge Research Institute say they have found how two genes from the same “family” can interact to stop cancer, reports News-medical.net.

A dilemma occasionally faced at the diagnostic stage is the challenge of distinguishing melanoma from look-alike Spitz nevi. … Spitz nevi are known to be benign -but their presence poses a problem because of their potential for leading to misdiagnoses.

The message the AAD wants people to get is that dermatologists - and only dermatologists - are the doctors who should be seen when skin problems arise.

National report - Changes to requirements for graduate medical education in dermatology have sparked protest by the American Society for Mohs Surgery (ASMS), even as some dermatologists say the society's concerns are unfounded.